These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1384726)

  • 1. The clinical relevance of salivary amylase monitoring in bulimia nervosa.
    Kronvall P; Fahy TA; Isaksson A; Theander S; Russell GF
    Biol Psychiatry; 1992 Jul; 32(2):156-63. PubMed ID: 1384726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alpha-amylase isoenzymes in serum and saliva of patients with anorexia and bulimia nervosa].
    Scheutzel P; Gerlach U
    Z Gastroenterol; 1991 Jul; 29(7):339-45. PubMed ID: 1950041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperamylasemia in bulimia nervosa.
    Walsh BT; Wong LM; Pesce MA; Hadigan CM; Bodourian SH
    J Clin Psychiatry; 1990 Sep; 51(9):373-7. PubMed ID: 1698766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperamylasemia in bulimia nervosa and hyperemesis gravidarum.
    Robertson C; Millar H
    Int J Eat Disord; 1999 Sep; 26(2):223-7. PubMed ID: 10422613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary gland enlargement and elevated serum amylase in bulimia nervosa.
    Metzger ED; Levine JM; McArdle CR; Wolfe BE; Jimerson DC
    Biol Psychiatry; 1999 Jun; 45(11):1520-2. PubMed ID: 10356637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme activities in the oral fluids of patients suffering from bulimia: a controlled clinical trial.
    Schlueter N; Ganss C; Pötschke S; Klimek J; Hannig C
    Caries Res; 2012; 46(2):130-9. PubMed ID: 22472533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled trial of d-fenfluramine in bulimia nervosa.
    Fahy TA; Eisler I; Russell GF
    Br J Psychiatry; 1993 May; 162():597-603. PubMed ID: 8149110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial of d-fenfluramine in bulimia nervosa.
    Russell GF; Checkley SA; Feldman J; Eisler I
    Clin Neuropharmacol; 1988; 11 Suppl 1():S146-59. PubMed ID: 3052813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperamylasemia in patients with eating disorders.
    Humphries LL; Adams LJ; Eckfeldt JH; Levitt MD; McClain CJ
    Ann Intern Med; 1987 Jan; 106(1):50-2. PubMed ID: 2431640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personality disorder diagnoses in patients with bulimia nervosa: clinical correlates and changes with treatment.
    Ames-Frankel J; Devlin MJ; Walsh BT; Strasser TJ; Sadik C; Oldham JM; Roose SP
    J Clin Psychiatry; 1992 Mar; 53(3):90-6. PubMed ID: 1548251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of bulimia with fenfluramine and desipramine.
    Blouin AG; Blouin JH; Perez EL; Bushnik T; Zuro C; Mulder E
    J Clin Psychopharmacol; 1988 Aug; 8(4):261-9. PubMed ID: 3062043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum salivary isoamylase levels in patients with anorexia nervosa, bulimia or bulimia nervosa.
    Blinder BJ; Hagman J
    Hillside J Clin Psychiatry; 1986; 8(2):152-63. PubMed ID: 3557291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetry of salivary cortisol and α-amylase responses to psychosocial stress in anorexia nervosa but not in bulimia nervosa.
    Monteleone P; Scognamiglio P; Canestrelli B; Serino I; Monteleone AM; Maj M
    Psychol Med; 2011 Sep; 41(9):1963-9. PubMed ID: 21284914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thirty-month outcome in patients with anorexia or bulimia nervosa and concomitant obsessive-compulsive disorder.
    Thiel A; Züger M; Jacoby GE; Schüssler G
    Am J Psychiatry; 1998 Feb; 155(2):244-9. PubMed ID: 9464205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of eating by fenfluramine in patients with bulimia nervosa.
    Robinson PH; Checkley SA; Russell GF
    Br J Psychiatry; 1985 Feb; 146():169-76. PubMed ID: 3856458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa.
    Neudeck P; Jacoby GE; Florin I
    Physiol Behav; 2001 Jan; 72(1-2):93-8. PubMed ID: 11239985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of bulimia among secondary school students in Casablanca].
    Ghazal N; Agoub M; Moussaoui D; Battas O
    Encephale; 2001; 27(4):338-42. PubMed ID: 11686055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperamylasemia and its relationship to binge-purge episodes: development of a clinically relevant laboratory test.
    Gwirtsman HE; Kaye WH; George DT; Carosella NW; Greene RC; Jimerson DC
    J Clin Psychiatry; 1989 Jun; 50(6):196-204. PubMed ID: 2470728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ipsapirone in the treatment of bulimia nervosa: an open pilot study.
    Geretsegger C; Greimel KV; Roed IS; Hesselink JM
    Int J Eat Disord; 1995 May; 17(4):359-63. PubMed ID: 7620475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom fluctuation in eating disorders: correlates of diagnostic crossover.
    Tozzi F; Thornton LM; Klump KL; Fichter MM; Halmi KA; Kaplan AS; Strober M; Woodside DB; Crow S; Mitchell J; Rotondo A; Mauri M; Cassano G; Keel P; Plotnicov KH; Pollice C; Lilenfeld LR; Berrettini WH; Bulik CM; Kaye WH
    Am J Psychiatry; 2005 Apr; 162(4):732-40. PubMed ID: 15800146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.